Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria-Reference-Cited by-同舟云学术

Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria

Published:2016-01-01 Issue:1 Volume:65 Page:1-8
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Soni Isha¹,De Groote Mary Ann²,Dasgupta Arunava¹,Chopra Sidharth¹

Affiliation:

1. Division of Microbiology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow 226031, Uttar Pradesh, India

2. Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523-1682, USA

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference38 articles.

1. Comparative Drug Resistance of Mycobacterium abscessus and M. chelonae Isolates from Patients with and without Cystic Fibrosis in the United Kingdom

2. Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria

3. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study

4. High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors

5. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment;European Journal of Medicinal Chemistry;2024-11

2. Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products;Current Topics in Medicinal Chemistry;2024-06

3. Polycationic phosphorous dendrimer potentiates multiple antibiotics against drug-resistant mycobacterial pathogens;Biomedicine & Pharmacotherapy;2024-04

4. In vitro and ex vivo activity of the fluoroquinolone DC-159a against mycobacteria;The Journal of Antibiotics;2024-03-04

5. CPMAS NMR platform for direct compositional analysis of mycobacterial cell-wall complexes and whole cells;Journal of Magnetic Resonance Open;2023-12